The PACS and RIS Market was valued at US$ million 2,836.65 in 2019 and is projected to reach US$ 5,441.87 million by 2027; it is expected to grow at a CAGR of 8.48% from 2019 to 2027.
The growth of the PACS and RIS market is mainly attributed to the factors such as developments in diagnostic imaging modalities coupled with rising number of diagnostic tests procedures and affordable price of new generation PACS software. However, the market is likely to get negatively impacted by the availability of better substitutes, and concerns regarding data privacy during the forecast period.
The picture archiving and communication system (PACS) manages, retrieves, stores, and distributes the medical images. In the field of radiology, it is used for sharing and viewing diagnostic images. A radiology information system (RIS) is a software system used for handling medical images and other associated data. RIS retains track of radiology imaging orders and data of bills. It is used along with PACS and vendor-neutral archives (VNAs). RIS manages image archives, keeps records, and billing.
During recent years, there have been various developments in imaging modalities within healthcare for diagnostic purposes. Radiology has developed as a recent trend towards computerized management in the health service and has responded to the demand for cost-efficient and rapid communication between radiology departments and their users. The national rate for CT scans were 126 per 1,000 individuals around 2014 and 2015. Rates ranged from 209 (New Brunswick) and 170 (Newfoundland and Labrador) to 88 (Alberta) and 93 (Prince Edward Island). In addition, according to the National Health Services (NHS) UK, there were 4.1 million imaging tests conducted in England in the 12 months from February 2017 to January 2017. Of these, 3.49 million imaging tests were reported to have taken place in January 2017. As per the World Health Organization (WHO), with improved health care policy and the guided protocol of medical imaging for COVID-19 diagnosis, there has been a rise in the number of global imaging-based procedures. Thus, the growing number of diagnostic imaging procedures performed across the globe resulting in the increasing requirement of consumables for tests are likely expected to drive the growth of the global PACS and RIS market over the coming years.
COVID-19 pandemic has become the most significant challenge across the world. The demand PACS and RIS have increased in hospitals due to COVID 19 as the fast and easily accessible patient imaging is crucial in treatment of COVID 19 sufferers. This has resulted in increased demand for picture archiving and communication systems (PACS), which in turn secure growth and sustainability in this market. In April, the U.S. Food and Drug Administration (FDA) has approved Intelerad’s InteleConnect EV solution for diagnostic imaging review on a range of mobile devices. This approval comes at a critical time for healthcare systems and ensures that radiologists are able to collaborate and leverage resources in more creative ways, even when workstation access is not available. It also is approved for mobile diagnostic image review, and can immediately be used on various iPad and iPhone models, with additional devices on the horizon. All the aforementioned factors are expected to bring positive prospects for PACS and RIS market during this pandemic crisis.
Global PACS and RIS market, based on products, is segmented into picture archiving and communication system (PACS) and radiology information system (RIS).The PACS segment is further segmented into orthopedic PACS, oncology PACS, cardiology PACS, dental PACS, and others. In 2019, the PACS segment accounted for the highest share of the market. Growth of this segment is attributed to increasing adoption of PACS systems in radiological procedures. The same segment is likely to register highest CAGR in the global PACS and RIS market during the forecast period. In sub segments orthopedic segment held major market share.
Based on component, the PACS and RIS market is segmented into software, hardware, and services. The software segment held the largest share of the market in 2019, and is anticipated to register the highest CAGR of 9.0 % in the market during the forecast period.
Global PACS and RIS market, based on deployment, the PACS and RIS market is segmented into Web-Based, On-Premise and Cloud-Based. The Web-Based segment held the largest share of the market in 2019, and Cloud-Based segment is anticipated to register the highest CAGR of 9.5% in the market during the forecast period.
Global PACS and RIS market, based on end user, the PACS and RIS market is segmented into hospitals, diagnostic centers, research and academic institutes, and other end users. The hospitals segment held the largest share of the market in 2019, and same segment is anticipated to register the highest CAGR of 8.9% in the market during the forecast period.
The Centers for Disease Control and Prevention, European Union, National Health Service, the Food and Drug Administration, the World Health organization, the American Dental Association, and Business Monitor International are among the major primary and secondary sources referred for preparing this report.
The growth of the PACS and RIS market is mainly attributed to the factors such as developments in diagnostic imaging modalities coupled with rising number of diagnostic tests procedures and affordable price of new generation PACS software. However, the market is likely to get negatively impacted by the availability of better substitutes, and concerns regarding data privacy during the forecast period.
The picture archiving and communication system (PACS) manages, retrieves, stores, and distributes the medical images. In the field of radiology, it is used for sharing and viewing diagnostic images. A radiology information system (RIS) is a software system used for handling medical images and other associated data. RIS retains track of radiology imaging orders and data of bills. It is used along with PACS and vendor-neutral archives (VNAs). RIS manages image archives, keeps records, and billing.
During recent years, there have been various developments in imaging modalities within healthcare for diagnostic purposes. Radiology has developed as a recent trend towards computerized management in the health service and has responded to the demand for cost-efficient and rapid communication between radiology departments and their users. The national rate for CT scans were 126 per 1,000 individuals around 2014 and 2015. Rates ranged from 209 (New Brunswick) and 170 (Newfoundland and Labrador) to 88 (Alberta) and 93 (Prince Edward Island). In addition, according to the National Health Services (NHS) UK, there were 4.1 million imaging tests conducted in England in the 12 months from February 2017 to January 2017. Of these, 3.49 million imaging tests were reported to have taken place in January 2017. As per the World Health Organization (WHO), with improved health care policy and the guided protocol of medical imaging for COVID-19 diagnosis, there has been a rise in the number of global imaging-based procedures. Thus, the growing number of diagnostic imaging procedures performed across the globe resulting in the increasing requirement of consumables for tests are likely expected to drive the growth of the global PACS and RIS market over the coming years.
COVID-19 pandemic has become the most significant challenge across the world. The demand PACS and RIS have increased in hospitals due to COVID 19 as the fast and easily accessible patient imaging is crucial in treatment of COVID 19 sufferers. This has resulted in increased demand for picture archiving and communication systems (PACS), which in turn secure growth and sustainability in this market. In April, the U.S. Food and Drug Administration (FDA) has approved Intelerad’s InteleConnect EV solution for diagnostic imaging review on a range of mobile devices. This approval comes at a critical time for healthcare systems and ensures that radiologists are able to collaborate and leverage resources in more creative ways, even when workstation access is not available. It also is approved for mobile diagnostic image review, and can immediately be used on various iPad and iPhone models, with additional devices on the horizon. All the aforementioned factors are expected to bring positive prospects for PACS and RIS market during this pandemic crisis.
Global PACS and RIS market, based on products, is segmented into picture archiving and communication system (PACS) and radiology information system (RIS).The PACS segment is further segmented into orthopedic PACS, oncology PACS, cardiology PACS, dental PACS, and others. In 2019, the PACS segment accounted for the highest share of the market. Growth of this segment is attributed to increasing adoption of PACS systems in radiological procedures. The same segment is likely to register highest CAGR in the global PACS and RIS market during the forecast period. In sub segments orthopedic segment held major market share.
Based on component, the PACS and RIS market is segmented into software, hardware, and services. The software segment held the largest share of the market in 2019, and is anticipated to register the highest CAGR of 9.0 % in the market during the forecast period.
Global PACS and RIS market, based on deployment, the PACS and RIS market is segmented into Web-Based, On-Premise and Cloud-Based. The Web-Based segment held the largest share of the market in 2019, and Cloud-Based segment is anticipated to register the highest CAGR of 9.5% in the market during the forecast period.
Global PACS and RIS market, based on end user, the PACS and RIS market is segmented into hospitals, diagnostic centers, research and academic institutes, and other end users. The hospitals segment held the largest share of the market in 2019, and same segment is anticipated to register the highest CAGR of 8.9% in the market during the forecast period.
The Centers for Disease Control and Prevention, European Union, National Health Service, the Food and Drug Administration, the World Health organization, the American Dental Association, and Business Monitor International are among the major primary and secondary sources referred for preparing this report.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global PACS and RIS Market - By Product
1.3.2 Global PACS and RIS Market - By Component
1.3.3 Global PACS and RIS Market - By Deployment
1.3.4 Global PACS and RIS Market - By End User
1.3.5 Global PACS and RIS Market - By Geography
2. PACS and RIS Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global PACS and RIS Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinions
5. Global PACS and RIS Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Developments in Diagnostic Imaging Modalities Coupled with Rising Number of Diagnostic Tests Procedures
5.1.2 Affordable Price of New Generation PACS Software
5.2 Key Market Restraints
5.2.1 Availability of Better Substitutes
5.2.2 Concerns Regarding Data Privacy
5.3 Key Market Opportunities
5.3.1 Increasing Demand for Orthopaedic PACS
5.4 Key Market Trends
5.4.1 Technology Advancement and New Product Launches
5.5 Impact Analysis
6. PACS and RIS Market - Global Analysis
6.1 Global PACS and RIS Market Revenue Forecasts And Analysis
6.2 Global PACS and RIS Market, By Geography - Forecasts And Analysis
6.3 Positioning of Key Players
7. Global PACS and RIS Market Analysis- by Product
7.1 Overview
7.2 Global PACS and RIS Market, By Product, 2019 & 2027 (% Share)
7.3 Picture Archive and Communication System (PACS) Market
7.3.1 Overview
7.3.2 Global Picture Archive and Communication System (PACS) Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.3 Orthopedic PACS Market
7.3.3.1 Overview
7.3.3.2 Global Orthopedic PACS Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 Oncology PACS Market
7.3.4.1 Overview
7.3.4.2 Global Oncology PACS Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.5 Cardiology PACS Market
7.3.5.1 Overview
7.3.5.2 Global Cardiology PACS Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.6 Dental PACS Market
7.3.6.1 Overview
7.3.6.2 Global Dental PACS Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.7 Others Market
7.3.7.1 Overview
7.3.7.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Radiology Information System (RIS) Market
7.4.1 Overview
7.4.2 Global Radiology Information System (RIS) Market Revenue and Forecasts to 2027 (US$ Mn)
8. Global PACS and RIS Market Analysis- by Component
8.1 Overview
8.2 Global PACS and RIS Market, By Component, 2019 & 2027 (% Share)
8.3 Software Market
8.3.1 Overview
8.3.2 Global Software Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Hardware Market
8.4.1 Overview
8.4.2 Global Hardware Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Services Market
8.5.1 Overview
8.5.2 Global Services Market Revenue and Forecasts to 2027 (US$ Mn)
9. Global PACS and RIS Market Analysis- by Deployment
9.1 Overview
9.2 Global PACS and RIS Market, By Deployment 2019 & 2027 (% Share)
9.3 Web-Based Market
9.3.1 Overview
9.3.2 Global Web-Based Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 On-Premise Market
9.4.1 Overview
9.4.2 Global On-Premise Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Cloud-Based Market
9.5.1 Overview
9.5.2 Global Cloud-Based Market Revenue and Forecasts to 2027 (US$ Mn)
10. Global PACS and RIS Market Analysis- by End User
10.1 Overview
10.2 Global PACS and RIS Market, By End User, 2019 & 2027 (% Share)
10.3 Hospitals Market
10.3.1 Overview
10.3.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Diagnostic Centers Market
10.4.1 Overview
10.4.2 Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Others Market
10.5.1 Overview
10.5.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
11. PACS and RIS Market Revenue and Forecasts to 2027 - Geographical Analysis
11.1 North America PACS and RIS Market Revenue And Forecasts To 2027
11.1.1 North America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.2 North America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.4 North America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.1.5 North America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.6 North America PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)
11.1.7 US PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.1 US PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.2 US PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.7.3 US America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.7.4 US PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.1.7.5 US PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.8 Canada PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.1 Canada PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.2 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.8.3 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.8.4 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.1.8.5 Canada PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.9 Mexico PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.1 Mexico PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.2 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.9.3 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.9.4 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.1.9.5 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2 Europe PACS and RIS Market Revenue And Forecasts To 2027
11.2.1 Europe PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.2 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.3 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.2.4 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.2.5 Europe PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.6 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Country (%)
11.2.7 UK PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.1 UK PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.2 UK PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.7.3 UK PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.2.7.4 UK PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.2.7.5 UK PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.8 Germany PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.1 Germany PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.2 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.8.3 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.2.8.4 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.2.8.5 Germany PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.9 France PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.1 France PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.2 France PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.9.3 France PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.2.9.4 France PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.2.9.5 France PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.10 Italy PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.1 Italy PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.2 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.10.3 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.2.10.4 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.2.10.5 Italy PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.11 Spain PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.1 Spain PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.2 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.11.3 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.2.11.4 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.2.11.5 Spain PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.12 Rest of Europe: Medical Device Adhesive Market - Revenue and Forecast to 2027 (USD Million)
11.2.12.1 Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.12.2 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.12.3 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.2.12.4 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.2.12.5 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3 Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027
11.3.1 Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.2 Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.3 Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.3.4 Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.3.5 Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.6 Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Country (%)
11.3.7 Japan PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.7.1 Japan PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.7.2 Japan PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.7.3 Japan PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.3.7.4 Japan PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.3.7.5 Japan PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.8 China PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.1 China PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.2 China PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.8.3 China PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.3.8.4 China PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.3.8.5 China PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.9 India PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.1 India PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.2 India PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.9.3 India PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.3.9.4 India PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.3.9.5 India PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.10 South Korea PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.1 South Korea PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.2 South Korea PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.10.3 South Korea PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.3.10.4 South Korea PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.3.10.5 South Korea PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.11 Australia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.1 Australia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.2 Australia PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.11.3 Australia PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.3.11.4 Australia PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.3.11.5 Australia PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.3.12 Rest of Asia Pacific: PACS and RIS Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.1 Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.12.2 Rest of Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.3.12.3 Rest of Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.3.12.4 Rest of Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.3.12.5 Rest of Asia Pacific PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4 Middle East & Africa PACS and RIS Market Revenue And Forecasts To 2027
11.4.1 Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.2 Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.3 Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.4.4 Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.4.5 Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.6 Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Country (%)
11.4.7 UAE PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.1 UAE PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.2 UAE PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.7.3 UAE PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.4.7.4 UAE PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.4.7.5 UAE PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.8 Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.1 Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.2 Saudi Arabia PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.8.3 Saudi Arabia PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.4.8.4 Saudi Arabia PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.4.8.5 Saudi Arabia PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.9 South Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.1 South Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.2 South Africa PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.9.3 South Africa PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.4.9.4 South Africa PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.4.9.5 South Africa PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.4.10 Rest of Middle East and Africa: Medical Device Adhesive Market - Revenue and Forecast to 2027 (USD Million)
11.4.10.1 Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.10.2 Rest of Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.4.10.3 Rest of Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.4.10.4 Rest of Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.4.10.5 Rest of Middle East & Africa PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5 South And Central America PACS and RIS Market Revenue And Forecasts To 2027
11.5.1 South and Central America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.2 South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.3 South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.5.4 South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.5.5 South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5.6 South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Country (%)
11.5.7 Argentina PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.7.1 Argentina PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.7.2 Argentina PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.7.3 Argentina PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.5.7.4 Argentina PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.5.7.5 Argentina PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5.8 Brazil PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.1 Brazil PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.2 Brazil PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.8.3 Brazil PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.5.8.4 Brazil PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.5.8.5 Brazil PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.5.9 Rest of South and Central America: PACS and RIS Market - Revenue and Forecast to 2027 (USD Million)
11.5.9.1 Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.9.2 Rest of South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.5.9.3 Rest of South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.5.9.4 Rest of South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.5.9.5 Rest of South and Central America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12. Impact of COVID-19 Pandemic on Global PACS and RIS Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. PACS and RIS Market- Industry Landscape
13.1 Overview
13.2 Growth Strategies In The PACS and RIS Market, 2017-2020
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies in the PACS and RIS Market, 2017-2020 (%)
13.4.1 Collaborations
13.4.1.1 Recent Collaborations By Players In The PACS and RIS Market
13.4.2 Agreements, Partnerships and Joint Ventures
13.4.2.1 Recent Agreements, Partnerships And Joint Ventures By Players In The PACS and RIS Market
13.4.3 Acquisitions
13.4.3.1 Recent Acquisitions By Players In The PACS and RIS Market
13.5 Organic Growth Strategies
13.5.1 Overview
13.6 Organic Growth Strategies in the PACS and RIS Market, 2017-2020 (%)
13.6.1 Product Launches
13.6.1.1 Recent Product Launches By Players In The PACS and RIS Market
13.6.2 Product Approval & Other Organic Growth Strategies
13.6.2.1 Recent Product Approval & Other Organic Growth Strategies By Players In The PACS and RIS Market
14. PACS and RIS Market-Key Company Profiles
14.1 Agfa-Gevaert Group
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 INFINITT Healthcare Co., Ltd.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Overview
14.2.4 Product Portfolio
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 McKesson Corporation
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Cerner Corporation
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 Product Portfolio
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 General Electric Company
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Overview
14.5.4 Product Portfolio
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Koninklijke Philips N.V.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Overview
14.6.4 Product Portfolio
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 FUJIFILM Holdings Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Siemens AG
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Overview
14.8.4 Product Portfolio
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 IBM
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 Product Portfolio
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Novarad
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Overview
14.10.4 Product Portfolio
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary Of Terms
List of Tables
Table 1. North America PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 2. North America PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 3. North America PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 4. North America PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 5. US PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 6. US PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 7. US PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 8. US PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 9. Canada PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 10. Canada PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 11. Canada PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 12. Canada PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 13. Mexico PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 14. Mexico PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 15. Mexico PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 16. Mexico PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 17. Europe PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 18. Europe PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 19. Europe PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 20. Europe PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 21. UK PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 22. UK PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 23. UK PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 24. UK PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 25. Germany PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 26. Germany PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 27. Germany PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 28. Germany PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 29. France PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 30. France PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 31. France PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 32. France PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 33. Italy PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 34. Italy PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 35. Italy PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 36. Italy PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 37. Spain PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 38. Spain PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 39. Spain PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 40. Spain PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 41. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 42. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 43. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 44. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 45. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 46. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 47. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 48. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 49. Japan PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 50. Japan PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 51. Japan PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 52. Japan PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 53. China PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 54. China PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 55. China PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 56. China PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 57. India PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 58. India PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 59. India PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 60. India PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 61. South Korea PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 62. South Korea PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 63. South Korea PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 64. South Korea PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 65. Australia PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 66. Australia PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 67. Australia PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 68. Australia PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 69. Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 70. Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 71. Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 72. Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 73. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 74. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 75. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 76. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 77. UAE PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 78. UAE PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 79. UAE PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 80. UAE PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 81. Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 82. Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 83. Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 84. Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 85. South Africa PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 86. South Africa PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 87. South Africa PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 88. South Africa PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 89. Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 90. Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 91. Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 92. Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 93. South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 94. South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 95. South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 96. South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By End user (US$ Mn)
Table 97. Argentina PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 98. Argentina PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 99. Argentina PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 100. Argentina PACS and RIS Market Revenue and Forecasts to 2027, By End user (US$ Mn)
Table 101. Brazil PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 102. Brazil PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 103. Brazil PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 104. Brazil PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 105. Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 106. Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 107. Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 108. Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 109. Recent Collaborations by Players in The PACS and RIS Market
Table 110. Recent Agreements, Partnerships and Joint Ventures by Players in The PACS and RIS Market
Table 111. Recent Acquisitions by Players in The PACS and RIS Market
Table 112. Recent Product Launches in the PACS and RIS Market
Table 113. Recent Product Approval & Other Organic Growth Strategies in the PACS and RIS Market
Table 114. Glossary of Terms, PACS and RIS MarketList of Figures
Figure 1. PACS and RIS Market Segmentation
Figure 2. PACS and RIS Segmentation, by Region
Figure 3. PACS and RIS Market Overview
Figure 4. Picture Archive and Communication System (PACS) Held Largest Share of PACS and RIS Market in 2019
Figure 5. PACS and RIS Market in Asia Pacific Region to Show Remarkable Growth During Forecast Period
Figure 6. Global PACS and RIS Market, By Geography (US$ Million)
Figure 7. Global PACS and RIS Market- Leading Country Markets (US$ Million)
Figure 8. Global PACS and RIS Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia - Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. PACS and RIS Market Impact Analysis of Driver and Restraints
Figure 15. Global PACS and RIS Market - Revenue Forecasts and Analysis - 2019- 2027
Figure 16. Global PACS and RIS Market - by Geography Forecasts and Analysis - 2019- 2027
Figure 17. Prominent Players in the PACS and RIS Market
Figure 18. Global PACS and RIS Market, by Product, 2019 & 2027 (% Share)
Figure 19. Global Picture Archive and Communication System (PACS) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Global Orthopedic PACS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Global Oncology PACS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Global Cardiology PACS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Global Dental PACS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Global Radiology Information System (RIS) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Global PACS and RIS Market, by Component, 2019 & 2027 ((% Share)
Figure 27. Global Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Global Hardware Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Global Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Global PACS and RIS Market, By Deployment, 2019 & 2027 (% Share)
Figure 31. Global Web-Based Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. Global On-Premise Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. Global Cloud-Based Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 34. Global PACS and RIS Market, By End User, 2019 & 2027 (% Share)
Figure 35. Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 36. Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. North America PACS and RIS Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 39. North America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. North America PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)
Figure 41. US PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. Canada PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Mexico PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. Europe PACS and RIS Market Revenue Overview, by Country, 2019 (US$ MN)
Figure 45. Europe PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 46. Europe PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)
Figure 47. UK PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 48. Germany PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. France PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 50. Italy PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. Spain PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 52. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 53. Asia Pacific PACS and RIS Market Revenue Overview, by Country, 2019 (US$ MN)
Figure 54. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 55. Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)
Figure 56. Japan PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. China PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 58. India PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. South Korea PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 60. Australia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 61. Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 62. Middle East & Africa PACS and RIS Market Revenue Overview, by Country, 2019 (US$ MN)
Figure 63. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 64. Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)
Figure 65. UAE PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 66. Saudi Arabia PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 67. South Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 68. Rest of Middle East & Africa PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 69. South and Central America PACS and RIS Market Revenue Overview, by Country, 2019 (US$ MN)
Figure 70. South and Central America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 71. South and Central America PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)
Figure 72. Argentina PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 73. Brazil PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 74. Rest of South and Central America PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 75. Impact of COVID-19 Pandemic on PACS and RIS market in North American Countries
Figure 76. Impact of COVID-19 Pandemic on PACS and RISs market in European Countries
Figure 77. Impact of COVID-19 Pandemic on PACS and RISs Market in Asia Pacific Countries
Figure 78. Impact Of COVID-19 Pandemic on PACS and RISs Market in Middle East and Africa Countries
Figure 79. Impact Of COVID-19 Pandemic on PACS and RIS Market in South and Central America Countries
Figure 80. Growth Strategies in the PACS and RIS Market, 2017-2020
Figure 81. Inorganic Developments in the PACS and RIS Market, 2017-2020 (%)
Figure 82. Organic Growth Strategies in the PACS and RIS Market, 2017-2020 (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agfa-Gevaert Group
- INFINITT Healthcare Co., Ltd.
- McKesson Corporation
- Cerner Corporation
- General Electric Company
- Koninklijke Philips N.V.
- FUJIFILM Holdings Corporation
- Siemens AG
- IBM
- Novarad
Table Information
| Report Attribute | Details |
|---|---|
| Published | January 2021 |
| Forecast Period | 2019 - 2027 |
| Estimated Market Value ( USD | $ 2836.65 Million |
| Forecasted Market Value ( USD | $ 5441.87 Million |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
